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Lung cancer is a leading cancer site in men andwomen with a high incidence and mortality rate. Most
patients are diagnosed when the disease has already spread. An early detection and immediate and
accurate histological or cytological diagnosis are essential for a hopeful outcome. In most patients,
bronchoscopy is the method of choice in establishing a suspected lung neoplasm. With the rigid and
flexible method, two complementary techniques are available. The methods bear a very low mortal-
ity rate if sufficient monitoring and resuscitative instrumentation is available. Rigid bronchoscopy
offers the possibility of obtaining large biopsy specimens from the tumorous tissue and provides an
effective tool in the control of major haemorrhage. However, it cannot be used for the inspection of
further peripherally located parts of the bronchial system and needs general anaesthesia. In contrast,
the flexible method can be quickly and readily performed at practically any location using portable
equipment. Bronchi can be inspected up to the 8th order and with bronchial washing, forceps biopsy,
brush biopsy and fluorescence bronchoscopy techniques with a high diagnostic yield are available.
This holds true, especially if these sampling techniques are used as complementary methods.
KEY WORDS: bronchoscopy, lung cancer, biopsy techniques
INTRODUCTION
In the majority of countries throughout the world, lung
cancer is the mostcommon and lethalform ofmalignancy.
Within the European community, this type oftumor is the
leading cancer site for males and, in the last few years,
this tumor type has even surpassed breast cancer as the
most frequent cause of cancer death in women (Bunn,
1991; Ginsberg et al., 1993).
The incidence of lung cancer currently exceeds 70 per
100,000 men (Ginsberg et al., 1993). In the European
community, approximately 157,000 cases of lung cancer
are newly diagnosed each year, 23,000 of which are in
women, leading to a death toll ofapproximately 135,000.
Thisnumberaccounts foraround30% ofallcancerdeaths.
While rates of increase for other types of tumors have
remained stable over the past 20 years, those for lung can-
cer mortality have actually climbed (Boring et al., 1991).
This increasehasbeencalculatedto stand at 10--15% every
5 years among males and is closely linked to prevailing
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smoking habits (Saccommano et al., 1976). During the
1980s however, the rate of increase was not as rapid as
was observed in former years, thereby reflecting a trend
towards cessation ofsmoking (National Center for Health
Statistics, 1991).
There are fourmajor histological subtypes forlung can-
cer: squamous cell carcinoma, adenocarcinoma, and large
cell carcinoma, which are referred as non-small cell car-
cinoma (NSCLC) and, the group of small cell carcinoma
(SCLC). Over the last decade, there has been an increased
tendency for adenocarcinomas, especially of the bron-
choalveolar type (Gazdar and Linnoila, 1988), along with
a decrease of the proportion of squamous cell cancers
(Valaitis et al., 1981; Vincent et al., 1977;Wu et al., 1986).
The presence of adeno- and bronchoalveolar carcinoma,
as well as, in part, the very heterogenous group of large
cell carcinoma, is observed more often within the periph-
eral parts of the lung, while squamous cell and small cell
carcinoma occur more centrally.
Mean5-year survival forpersons with lungcancerstands
at only 13% (Ginsberg et al., 1993). This is reflectedby the
fact that the majority of patients are diagnosed, once the
disease has already spread to distant sites. Therefore, the
only chance ofhopeful survival is an optimal management10 R.W. HAUCK AND H. P. EMSLANDER
of the diagnostic tools with detection of the tumor before
the disease has reached an incurable stage. This aim can be
realizedthroughimmediateand accurate histological orcy-
tological diagnosiscombinedwithacomplete staging. This
is particularly relevant owing to the significant differences
in survival at different stages of disease and to the differ-
enciated therapeutic modalities currently available. In one-
half of the cases, if a roentgenologically occult cancer is
suspected, it will be visible at a first bronchoscopic in-
spection (Edell and Cortese, 1989). Those patients with an
early stage, radiographically occult tumor do especially
benefit from this approach demonstrated by the overall 5-
year survival rate of90% (Feruson, 1990).
Following careful collection ofpatienthistory andphys-
ical examination, the first reasonable step in the sequence
of diagnostic evaluation is a chest roentgenogram which
provides the mostpreliminary ofinvestigations, should the
diagnosis of lung cancer be suspected (Feruson, 1990).
Usually a ’T’-classification ofthe tumor, according to the
TNM-staging protocol, can be assigned and some infor-
mation pertaining to nodal enlargement ("N") is obtained.
Other relevant findings include pleural effusion, di-
aphragmatic elevation and lobar atelectasis or dystelecta-
sis. The next noninvasive staging assessment is
computerized tomography of the chest, which allows as-
sessmentoftumormarginsanddimensions. Itcan alsohelp
in distinguishing malignant from nonmalignant lung and
lymph nodes. Additionally, infiltration of the pleura may
be observed. Sputum cytology can be of diagnostic value
especially for centrally located tumors (Feruson, 1990).
Most often, the information derived from these nonin-
vasive diagnostic steps provides the basis fora subsequent
invasive procedure. These are either methods which are
performed via endoscopy or over a transthoracic route.
For peripheral lung tumors or pleurally based lesions the
transthoracic route carries ahigher diagnostic yield in that
it is performed using bronchoscopical techniques. The
golden standard fortransthoracic biopsy is achieved using
openlungbiopsy, withadiagnostic yieldofapproximately
95% and low mortality (Venn et al., 1985). Within the last
century, percutaneous needle biopsy has been well estab-
lished forthe diagnosis ofmid-and peripheral lung lesions
but the good diagnostic yield (-80%) is associated with a
high rate of pneumothoraces (Berquist et al., 1980; Poe
et al., 1984). Recently, less invasive techniques, i.e., tho-
racoscopic and videothoracoscopic lung biopsies, are
available to harvest large tissue specimens by means of
minimal surgical techniques (Feruson, 1990; Boutin etal.,
1982; Bensard et al., 1993). However, for endobronchial
lesions, atelectasis, or lobar consolidation, such methods
cannotbe recommended for use as a diagnostic procedure
(Westcott, 1980).
In parallel to optimized surgical techniques for harvest-
ing lung parenchyma, the endoscopical methods for diag-
nosis oflung cancer have steadily improved over the last 25
years. Today, fiberbronchoscopy is the method ofchoice in
establishing a suspected lung neoplasm in most patients.
BRONCHOSCOPY--TECHNIQUES AND
INSTRUMENTS
Two complementary techniques are available for bron-
choscopy, each offering different merits and disadvan-
tages (Table 1). Respiratory physicians usually prefer the
flexible bronchoscopy, while thoracic surgeons tend to
preferthe rigidtechnique. Ifone is familiarwithboth tech-
niques, it is also possible to pass the flexiblebronchoscope
through the rigid instrument which allows the advanta-
geous use ofboth instruments. In the hands ofexperienced
and skilled operators, both methods are safe and associ-
ated with minimal complications. The mortality is very
low and stands at 0.002-0.3% (Surrat et al., 1976).
Premedication
Premedication consists ofthe subcutaneous application of
0.5-1 mg of atropine, 30 minutes prior to the investiga-
tion which reduces mucus secretion and counteracts vagal
stimulation. Fifty to 100mg ofmeperidinecanbeadmixed
to the atropine, thereby providing a reliable antitussive
and analgetic effect (Nakhosteen et al., 1989). Addition-
ally, local anaesthesia must be applied, for example with
lignocaine. This can be performed by means of a hand at-
omizer, with the aid of small swabs soaked in anesthetic
solution orby drug nebulization. When the bronchoscope
has been inserted to the larynx, the vocal cords, trachea
and bronchibecome anaesthetizedby injecting lignocaine
Table 1 Comparison of properties from rigid and flexible bron-
choscopy
Rigid Flexible
bronchoscopy bronchoscopy
Local anaesthesia (+) +
General anaesthesia + (+)
Clarity of view +++ +++
Mucosal aspect +++ ++
Inspection of upper lobes (+) +++
Visible generations of bronchi -2nd -10th
Sampling of proximal airways ++ +++
Sampling of mid and peripheral (+) +++
airways
Size of biopsy specimen +++ ++
Removal of foreign bodies +++ ++
Management of major haemorrhage +++ +
Risk for morbidity + (+)
Risk for mortality (+) (+)
Costs ++ +BRONCHOSCOPY OFLUNG CANCER 11
with a syringe through the working channel of the scope
(DeKock, 1977; Brown, 1984).
Monitoring
Cardiac rhythm should be continuously monitored by
ECG during and shortly following the investigation along
with blood pressure in all patients undergoing bron-
choscopy. Additionally, the arterial oxygen saturation
mustbe assessed, usuallybymeans ofnoninvasive devices
(Fulkerson et al., 1993). Two methods are available with
earoximetry and transcutaneous measurement ofthe oxy-
gen saturation in the capillary blood, which provide ac-
curate data for this parameter (Saunders et al., 1976;
McDowell and Thiele, 1980). Supplemental oxygen of
1-2 l/rain can be administered to patients throughout the
investigation, and regularly to those with an arterial paO2
of less than 70 mm Hg (Fulkerson et al., 1993). Because
bronchoscopy is an invasive method and can lead to situ-
ations of emergency, the direct availability of resuscita-
tive instrumentation is obligatory.
Rigid Bronchoscopy
Rigid bronchoscopy is usually performed under general
anesthesiawhich is oftencombinedwith intravenousmus-
cle relaxation. Oxygen-Venturi systems are often used to
provide a sufficient gas exchange during the procedure
(Sanders, 1967). Alternatively, good results for oxygena-
tion are obtained through the use of high-frequency pos-
itive-pressure ventilation (Eriksson and Sjtstrand, 1977;
Munteanu et al., 1986). The bronchoscope is a straight
tube which is positioned into the tracheobronchial tree of
the supine patient. Scopes are available in different cal-
ibers ranging from 3 to 8.5 mm. The fight-sized scope is
one whichjustpasses the vocal cords with ease. The scope
usually incorporates a seperate channel for the applica-
tion of oxygen and anesthetics as well as a second one
through which catheters may be passed. For the broncho-
scopes, telescopes 30 cm in length with different angles
of vision (0, 30, 90) are available which can be posi-
tioned through the observers port. These freely inter-
changeable viewing telescopes can be connected with a
cold light source. With the telescopes, which provide ex-
cellent optics, inspection at least to the level of segmen-
tal and first subsegmental bronchi is possible. The rigid
bronchoscope offers the possibility to observe the trachea
and the proximal parts of the main bronchi with a direct
naked eye view and without any distortion evoked by an
optical device. This provides the most natural and realis-
tic investigation of structural deformities, abnormal rigid-
ity and alteration to the mucosa.
In diagnosing lung cancer, the rigid bronchoscope of-
fers the possibility to obtain a large biopsy specimen from
the tumorous tissue by means of specially designed for-
ceps’s devices, which can be passed through the observers
port. Through this large channel, a potential hemorrhage
can be easily controlled by intense suction, insertion of a
distensible balloon or a rigid tube, by electrocautery or
cryocoagulation.
It is a disadvantage, however, that inspection of further
peripherally located parts of the bronchial system is im-
possible with the rigid scope and that long and flexible in-
struments cannot be used in the sampling of peripheral
lesions. Moreover, this investigation cannot be imple-
mented as a bedsite method and usually requires general
anesthesia that requires a well-trained and experienced
nurse and technical staff, leading to an increase of costs
for the investigation.
Flexible Bronchoscopy
Since its introductionby Ikeda in 1968 (Ikeda et al., 1968),
the flexible bronchofibrescope has led to great progress in
the practice of bronchoscopy. This is due to several ad-
vantages in comparison to the rigid method. Depending
upon the situation, the scope can be introduced orally or
via the transnasal route. Beside this, it is possible in in-
tensive care situations to insert the instrument through a
endotracheal or tracheostomy tube. Bronchoscopy with a
flexible instrument can be performed under local anes-
thesiawith some sedation. In cases ofrespiratory impaired
patients, the method can even be carded out under general
anesthesia with artificial ventilation (see above). Flexible
bronchoscopy can be quickly and readily performed at
practically any location using portable equipment and, if
required, by a physician without additional staff.
Over the past 20 years, the quality and technical details
of flexible scopes have been constantly improved upon.
Today, bronchofiberscopes are available with a length
ranging from 70-80 cm, thereby allowing sufficient ac-
cess to even the very distal bronchi. The outer diameter
of the instruments varies from 3.6 to 6.4 mm. In relation
to this size, sucking channels from 1.2 to 3.2 mm are in-
ternally provided. Additionally, ultrathin instruments are
available with an outer diameter of 2 ram, and no work-
ing channel (i.e. Olympus XPF-25 A-5 or XPF-I$ N-5).
These instruments can be passed through the sucking
channel of a normal-sized scope. This "mother-baby
scope" technique allows inspection of the bronchi down
to the 7th or 8th order. The normal sized bronchoscope
contains a flexible bundle of approximately 14,000 glass
fibers, each with a diameter of 10 to 15 prn. Together with
the lens system at the proximal and distal end ofthe bron-12 R.W. HAUCKAND H. P. EMSLANDER
choscope, an image is received which is different from
that naturally obtainedby a direct inspection with the rigid
scope. The angle of view varies from 90 to 120 depend-
ing upon the instrument. The magnification, evoked by
the lens system, amounts to 2.5-3. The distal end of the
bronchoscope can be angulated, thereby allowing en-
trance to the lobar or segmental bronchi. Based upon the
type of scope used, a forward angulation from 160-180
and a backward flexion of 100 to 130 is possible. In con-
trast to gastroscopes, the tip ofthe bronchoscope can only
be moved in a single plane, steered by a fine wire system.
Together with rotation of the whole instrument a view in
any direction is allowed.
Bronchoscopic Inspection
Bronchoscopy permits direct inspection of the tracheo-
bronchial tree and facilitates diagnosis of lung cancer
along with the guided biopsy of suspective tissue struc-
tures. The method is essential in evaluating patients for
subsequent surgery in that the anatomical behavior ofthe
tumor is directly scrutinized.
During inspection for tissue or structures suspected for
carcinoma, it is important to explore the entire tracheo-
bronchial tree at all of its accessible parts as thoroughly
as possible. If secretions are present, they must be care-
fully removed to provide an unrestricted view of all the
luminal structures. Hereby, damage to the bronchial mu-
cosa must be avoided in that this can lead to bleeding
which would once again obscure the view. Tumors or en-
larged lymph nodes can be indicated by three types of di-
rect tumor signs: 1. exophytic intraluminal growth with
stenosis of the inner surface (Fig. 1); 2. infiltration of the
bronchial wall (Fig. 2); 3. distortion and compression of
normal anatomic structures (Fig. 3).
The most intraluminal tumors are visible as irregular
structures replacing the normal mucosa. Tumorextentcan
vary from a localized mucosa alteration to a solid tumor,
resulting in a partial to total occlusion the bronchial lumen
(Fig. 1). These tissues frequently consist of greater
necrotic parts and their color may impone from red to
eggshell and whitish. Those visible tumors are mostly
primary lung cancers or carcinoidtumors, whereas metas-
tases from other primary sites are commonly located in
the lung parenchyma. Benign endoluminal tumors usu-
ally have a characteristically hard consistency and an in-
tact covering mucosa.
Lung cancer which has less intensively infiltrated the
bronchial wall may just impone either on a narrowed
lumen of the bronchi, on an altered structure of the
bronchial mucosa or by teleangiectatic blood vessels.
Additionally, those areas become more suspicious, due to
Figure I Exophytic carcinoma (histology: squamous cell carcinoma)
ofthe rightmainbronchus seen through a video-optic chipbronchoscope
(Olympus, BF-XT 30).
an increased fragility of the blood vessels following con-
tact with the bronchoscope. Often, enlarged and pene-
trated lymph nodes, as well as centrally located and
ulcerated tumors may be identified which may have led
to dislocation and compression of the normal anatomic
structures of the bronchial tree.
Beside these direct tumor signs, the bronchial system
must be inspected as well for such indirect evidences of
malignancy as (Stradling, 1976): 1. vocal chord paralysis;
2. thickened and immobile bifurcation; 3. rigid and fixed
Figure 2 Intrinsic carcinoma of the lungs with bulging (,I,) the
bronchus wall close to ostiums of the right lower lobe seen through a
video-optic chip bronchoscope (Pentax, EB 2000).BRONCHOSCOPY OF LUNG CANCER 13
1986). Fluorescent compounds such as hematoporphyrin
dedvate (HpD) or its purified form dihematoporphyrin
ether(DHE) are preferentially retained by malignant cells
andby tissue with cellular atypia. Because those cells con-
centrate these compounds in contrast to nonmalignant
cells, they can be identified with several bronchoscopic
detection systems through a higher emission of red fluo-
rescence following excitation by ultraviolet light (Edell
and Cortese, 1989; Lam et al., 1993; Kato et al., 1984).
Very recently it could be shown that comparable results
can be obtained without the use offluorescentcompounds
(Edell and Cortese, 1989) through the use ofspectroscopy
during bronchoscopic investigation with a multichannel
analyzer and a helium cadmium laser.
Figure 3 Extrinsic carcinoma of the lungs (histology: small cell car-
cinoma) leading to distorsion and compression of anatomic structures
in its neighbourhood seen through a fibroptic bronchoscope (Olympus,
BF-XT 30).
bronchial structures at breathing or coughing maneuvers;
4. deviation or cessation of mucosal corrugations; 5. im-
pairment offluid drainage into the periphery visible at the
bronchial ostium.
Hoarseness in association with lung tumors is mostly
due to paralysis ofthe vocal chords. This indirectly points
to an infiltration of the laryngeal nerve at its intrathoracic
course by tumor tissue or enlarged lymph nodes. Within
the trachea and the proximal bronchial system tumor
masses can lead, by pressure from the external site, either
to bulging of the inner bronchial lumen, to distortion of
the airways (Fig. 3) or to widening and fixation ofthe bi-
curcation of the trachea (Fig. 2). If it is impossible to vi-
sualize thetumor directly, the detection ofrigid, immobile
or hyperplastic airway structures can provide reliable aid
in the decision as to wherebiopsy samples shouldbe taken
from. Tumor masses growing close to the airway wall
often disturb the normal aspect of mucosal corrugations
which must be documented with thorough bronchoscop-
ical inspection. In addition, the presence of an invisible
obstruction within the distal parts of the bronchi can be
suspected ifanesthetics orlavage fluids demonstrate a loss
of their run off to the lung periphery at the level of the ca-
rina.
Fluorescence bronchoscopy can be potentially useful
in the imaging and procuring of malignant tissue (Lam et
al., 1993), especially in the diagnosis of occult lung can-
cer, early cancer, or early invasive squamous cell carci-
noma, stages in which therapy often provides an excellent
prognosis (Feruson, 1990; Hayata et al., 1984; Kato et al.,
Possible Complications
Lignocain, which is widely used for local anesthesia, can
lead to toxic side effects. Adverse reactions may occur as
broncho- orlaryngospasm (Ruffles and Gayres, 1987), loss
of consciousness, hypotension, or in the form of convul-
sions. Therefore, it is recommended not to exceed a total
dose of500mg or24ml ofthe2% solution (DeKock, 1977;
Grimes and Cates, 1976). Use of the 2% solution seems to
can’y a lower risk for side effects, yet an equal effective-
ness, than the 4% solution (Brown, 1984). To prevent the
induction of bronchospasm in asthmatics, premedication
with 50 mg of methylprednisolone is recommended fol-
lowed by albuterol administered as an intrabronchial in-
stillation (Nakhosteen, 1978). The lattercan also be used to
treat attacks of severe coughing induced by bronchoscopy.
Because themedal partial pressure ofoxygen can decrease
by about 20 mm Hg during bronchoscopy (Dubrawsky et
al., 1975; Emslander et al., 1980), patients should be routi-
nously supplied with supplemental oxygen during the pro-
cedure to avoid hypoxemia. Rarely cardiac arrythmias
occur, mostly in patients with coronary heart disease. In
10-20% of the patients (Fulkerson et al., 1993; Edksson
and Sj6strand, 1977), especially after bronchoalveolar
lavage, fever up to 39 can occur, which usually relieves
within 8 hours without specific therapy (Table 2).
Table 2
Complicationsfrom Bronchoscopy
Drug reaction
Bronchospasm
Laryngospasm
Convulsive cough
Hypoxemia
Cardiac arrythmia
Fever14 R.W. HAUCKAND H. P. EMSLANDER
Performed by a skilled physician, bronchoscopy is sel-
dom if ever contraindicated, especially when a suspected
lung rumor must be verified. Relative contraindications
existinextremelyimpairedorintenselydyspnoeicpatients
and in patients with recent myocardial infarction
(DeKock, 1977).
Bronchoscopical Sampling
Each patient suspectedofhavingapulmonarytumorbased
upon the results obtained from noninvasive procedures
should undergo cytological or histological confirmation of
thediagnosis (Feruson, 1990). Differentmethodsofbiopsy
for the harvesting of tumor tissue are available (Fig. 4).
The method with the highest diagnostic yield should be
selected, taking into careful consideration, however, the
patient’s physical condition (Table 3).
Bronchoalveolar Lavage (BAL)
In the past, BAL was widely used as a research tool which
provided access to cells and proteins from the lung pe-
riphery. However, previousreportshavedemonstrated that
BAL can be useful for the diagnosis ofprimary lung can-
cer and metastatic malignancies (Rennard, 1992;
Pirozynski, 1992; Levy et al., 1988), especially in cases
where the lesions are notendoscopically visible (Table 3).
Here, theBAL has a diagnostic yield ofabout65% (Levy
et al., 1988; Cortese et al., 1979), which in part is depen-
dent upon the size (diameter >3 cm) and type of the un-
derlying tumor. Higher diagnostic yields are obtained for
alveolar cell lung cancer and for adenocarcinomas
(Pirozynski, 1992; Linder and Rennard, 1988; Lundgren
et al., 1983). Complications with BAL are nearly negli-
gible. Minor side effects afterBAL consist in some cases,
Figure 4 Close-up photograph of the tip of different types of biopsy
instruments for use with the fiberoptic bronchoscope. At the top, a 20
gauge needle and a brash, at the bottom a cup and an alligator forceps,
each inserted in the working channel of a flexible bronchoscope.
oftransient fever as well as in a short-term decline in lung
function testing. Rarely, pneumothorax can occur as well
as slight bleeding, but these complications are below the
frequency seen with other biopsy methods (Rennard,
1992). In visible tumors, bioptic techniques yield supe-
rior results in affirming the diagnosis however, in periph-
erally located cancers cytological techniques are superior
(Kvale et al., 1976). The diagnostic yield of the BAL can
be increased by performing the lavage following all other
sampling methods and rises with the size ofthe suspected
lesion (Pirozynski, 1992). False-positive results are not
Table 3 Diagnostic yields and complication rates of different bronchoscopical biopsy techniques.
Method Diagnostic Pneumo horax Haemorrhage
Yield
Morbidity Mortality
Endobronchial biopsy: 76-96%5o:s2;69 O 057
Bronchoalveolar lavage:
Visible lesion 79%69 <0.1%39 <0.1%39
Non-visible lesion 43-65%4o,0
Brushing technique:
Visible lesion 92%69
Nonvisible lesion 25-67%so;5;;6
Transbronchial needle
biopsy: 33-76%5;63;65;67
Transbronchial forceps
biopsy:
Lesion <4 em 58%61
Lesion >4 cm 81%61
0.45%58
<2%39
0.01--0.04%58;59
<0.139%
<1%51:67;7o 051;70 051 061;67
0.01-5.5%58;59;61;7o 4%6s 1.4-7%6;6s 0.12%59
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reported (DeGracia et al., 1993), whereas cell-type dif-
ferences between the diagnosis of malignancy obtained
fromBAL samples compared to histological biopsies can
occur in about 20-40% (Pirozynski, 1992; Linder et al.,
1987). Additionally, dysplastic alterations of the har-
vested cells in patients with pneumonia, viral infections,
tracheostomy, radiotherapy or chemotherapy must be
taken into consideration while it can make it difficult to
distinguish these cell from those with malignant alter-
ations (Johnston et al., 1991).
The BAL is carded out by the administration of a total
volume of20-200ml (alliquots of20 ml) ofwanned0.9%
NaC1 with a hand-held syringe through the working chan-
nel ofthe bronchoscope into the region of interest. Ifonly
a defined suspicious segment ofthe lung shall be lavaged,
it is possible to instill the washing solution to this area
under the guidance of a small ERPC-catheter. Following
gentle aspiration, the returned samples are pooled and
processed. A recovery of 30% or more from the injected
volume can be considered as representative (Pirozynski,
1992; DeGraciaetal., 1993; KlechandPohl, 1989). Saline
washings should be dispatched to the laboratory immedi-
ately in that cell morphology deteriorates rapidly upon
storage (Brown, 1984).
Brushing Technique
Similarily to the BAL, brush biopsy is nearly free of rel-
evant complications (Schenk et al., 1986). The method is
used for the diagnosis of both visible tumors and lesions
which are not visible endoscopically as well for tumors
located in parts of the tracheobronchial tree which cannot
be reached by forceps biopsy. The method offers a diag-
nostic yield (Table 3) which for visible tumors, amounts
to approximately 90% (Haponik et al., 1988) and for non-
visible lesions to approximately 25-67% (Pirozynski,
1992; Maket al., 1990; Shure, 1983; Cortese et al., 1979;
Ellis, 1975). Either "blind", by brushing the suspected
lung segment after determination by posteroanterior and
lateral chest X-rays (Mak et al., 1990) or under fluoro-
scopic guidance, this method is reliable but can be opti-
mized by the additional use of other biopsy techniques.
Togetherwithtransbronchialbiopsy, theyieldcan increase
to around 95% for visible and to 75% for nonvisible tu-
mors(Mak etal., 1990; Shure, 1983;Popovich etal., 1982;
Cortese et al., 1979). However, even then, the failure rate
for diagnosing lung cancer amounts to 25-35%.
Several types of flexible brushes are available. Naked
brushes are just mounted at the tip of a leading catheter,
protected brushes are covered by a thin plastic tube which
can be removed immediately before the sample shall be
obtained. The catheter is inserted through the working
channel ofthe bronchofiberscope and positioned at the re-
gion of interest. To harvest cells, the brush can be slightly
moved in an up-down motion along the tissue and rotated
about. The brushings are then smeared on three or four
slides and fixed in 95% alcohol until investigation.
Endobronchial Biopsy
Endobronchial biopsy is the golden standard for sampling
endoscopically visible tumors andtumorous alterations of
tracheal and bronchial mucosa (Table 3). The method pro-
vides a yield of positive diagnosis ofmalignancy in about
96% (Mak et al., 1990; Popovich et al., 1982; Haponik et
al., 1988) and allows a high rate (80%) ofaccuracy in pre-
dicting cell type (Bayne et al., 1979). If the tumor is well
visible, the yield is greater than in "blind" biopsy. In the
latter case, a positive diagnosis constitutes about 45% of
the cases but only with an accuracy of60% (Bayne et al.,
1979). Often biopsies from even "normal mucosa" can be
useful in order to exclude submucosal infiltrative carci-
noma. In selecting the site for taking a biopsy necrotic or
hypervascular areas should be avoided. Usually endo-
bronchial forceps biopsy carries a low risk for haemor-
rhage except for patients with clotting abnormalities,
uremia or pulmonary hypertension (Zavala et al., 1988).
Three major groups of forceps are available in varying
sizes (3-5 mm): Cup forceps, fenestrated forceps, alliga-
tor forceps, and forceps with a inside thorn. It is not nee-
essarytoharvestalarge specimen, it is ofmoreimportance
to select from the fight place (Stradling, 1976). So far, it
is not clarified what is the optimal number of biopsies to
secure an adequate tissue diagnosis. However, 3-5 biop-
sies from central visible tumors (Popovich et al., 1982;
Kvale, 1978; Fechner et al., 1977) and up to 10 biopsies
from peripheral carcinomas are generally recommended
(Popovich et al., 1982). A single biopsy should be re-
garded as technically inadequate if malignant cells could
not be harvested (Pirozynski, 1992) (Table 4).
Transbronchial Biopsy
Lung cancer which is beyond the visible bronchi can be
diagnosed by means of transbronchial biopsy. A well-cir-
cumscribed peripheral lung lesion biopsy is carded out
Table 4
Influences on Diagnostic YieM ofLung Biopies
Location of the lesion: (proximal/distal)
Site of the tumor (intra-/extraluminal)
Size of lesion
Number of biopsies
Combination of sampling techniques16 R.W. HAUCKAND H. P. EMSLANDER
under fluoroscopic guidance. The closed forceps is passed
to the tumor and following injection of 3-5 ml of epi-
nephrin (1:10,000) the biopsy specimens are taken. After
takingthebiopsy, itisremovedfromtheforcepsandplaced
into 10% formol saline until its processing. For diffuse
processes i.e., lymphangiosis or alveolar cell carcinoma,
the forceps are either engaged to the most suspicious area
previously demonstrated on chest X-ray, or on computed
tomography, or preferably placed to the lateral segment
($9) of the lower lobe. Usually 4-6 specimens are taken
(Zavala et al., 1988). To avoid a possible bilateral air leak,
biopsies are only allowed from one lung side. The overall
mortality rate oftransbronchial biopsy amounts to 0.12%,
the rate of major complications to 2.7% (Simpson et al.,
1983). Transbronchialbiopsy carries an incidenceofpneu-
mothorax from 0.01 to 5.5% (Table 3) depending upon the
site of the lesion from where the biopsy is taken and
whether or not radiological screening is used for the pro-
cedure (Hanson and Collins, 1990; Simpson et al., 1983;
Ellis, 1975; Haponik et al., 1988). To prevent bleeding
complications, patients should provide normal prothrom-
bin time, activated partial thromboplastin time, platelet
count and should not suffer from clotting abnormalities.
At a peripheral biopsy, the risk formajorbleeding is lower
compared to biopsies from more central parts ofthe lungs
because of its smaller sized blood vessels (Hanson and
Collins, 1990). The overall diagnostic yield of trans-
bronchial biopsy amounts to 67-80%. For peripheral le-
sions below 4 cm in diameter, the rate is 58%; for larger
tumors, it rises to 81% (Cortese et al., 1979; Ellis, 1975).
Transbronchiai Needle Aspiration
Needle aspiration via the flexible bronchoscope is mainly
applied in diagnosing bronchogenic carcinoma metasta-
sising to hilar or mediastinal nodes (Wang, 1983). In a se-
ries of 363 patients with newly diagnosed cancer of the
lung, this method yielded positive mediastinal aspirates in
34% (Harrow et al., 1989). Due to its central origin, the rate
for diagnosing small-cell carcinoma is twice as high as for
non-small cell cancers. Interestingly, this method also pro-
vides positive results forN2 nodes (ipsilateral mediastinal
or subcarinal lymph nodes) if no abnormality of the chest
X-ray (46%) or tracheobronchial tree (38%) to this point is
visible (Harrow et al., 1985). The diagnostic yield for de-
tecting N2 disease stands at 77% and offers a specificity
close to 100% (Wang et al., 1983; Schenk et al., 1986).
Along with this, transbronchial needle aspiration is
commonly used for the sampling of extrabronchial and
peripheral tumors as well as for lesions compressing the
bronchus leading to an avoidance of forceps placement.
Additionally, needle aspiration can provide sufficient
specimens from grossly necrotic tumors and can be con-
sidered for use in the diagnosis of highly vascularized
masses (Table 5). The size of the lung mass directly in-
fluences the diagnostic yield of the procedure (Shure and
Fedullo, 1983) with a significant increase in positive re-
suits forlesions exceeding 2cm in size (33% versus 76%).
Ifused in combination with bronchial wash and brush for
lesions exceeding 2 cm, transbronchial needle aspiration
appears tobe superior to transbronchial biopsy (Shure and
Fedullo, 1983). The method is safe and very rarely asso-
ciated with complications such as severe bleedings
(Harrow et al., 1989; Shure and Fedullo, 1983) (Table 3).
Aspiration needles usually have a size of 20-23 gauge
by 1 cm. They are attached to a Teflon tubing and housed
in a metal sheath, in which the needle can be retracted for
the passage through the working channel of the broncho-
scope. At the end ofthe catheter, a syringe can be attached
to create suction for aspiration. Usually, two or three punc-
tures are performed at each biopy site. To avoid contami-
nation of malignant cells, needle biopy should always
precede other diagnostic procedures (Zavala et al., 1988).
Harvested cells shouldbe collected as previously described.
Summary
Lung cancerhas advanced to a position as the leading ma-
lignant disease in most countries ofthe world. To provide
an optimal chance for a hopeful outcome, it is essential to
assure a firm tissue diagnosis for planning the therapeu-
tic approach. Depending upon the location and spread of
the cancer, more or less invasive diagnostic procedures are
available. In recent years bronchoscopy has become the
most commonly used tool in establishing suspicious le-
sions, evident on chest X-ray. About two-thirds of all tu-
morous alterations can be seen by endoscopy directly or
indirectly and can be biopsied to affirm a tissue diagno-
sis. With the rigid and flexible bronchoscopy, two com-
plementary endoscopical techniques are available. Due to
its easy availability, lack of need for general anesthesia
and the possibility to inspect bronchi even to the 7th or
8th order, flexible bronchofiberscopes are presently most
commonly used. With visible lesions, forceps biopsy,
bronchial washing andbrush biopsy shouldbe performed,
Table 5
Indicationsfor Transbronchial Needle Aspiration
Mucosal infiltration
Mediastinal and extrabronchial lymph node enlargement
Extrinsic tumor with compression of the bronchial tree
Necrotic tumor mass
Vascular, carcinoid tumorBRONCHOSCOPY OFLUNG CANCER 17
if possible, as complementary methods to raise the diag-
nostic yield. For the diagnosis of nonvisible, more pe-
ripherally growing lung cancer, transbronchial biopsies,
brushings, needle aspiration under fluoroscopic guidance,
and selective washings are the most reliable methods. In
cases ofcarcinoma in situ fluorescencebronchoscopy can
assist to localize such lesions. For each kind of lesion, the
combination of different sampling methods increase the
probability of obtaining a firm histological and cytologi-
cal diagnosis, without a relevant increase of side effects.
Along with these excellent diagnostic properties, bron-
choscopy provides the possibility for the administration of
a variety oftreatments suitable forthe palliationoflung neo-
plasms. The available methods include stent implantation,
laser therapy, cryotherapy, fulguration, injection of locally
acting cytotoxic drugs, insertion of radioactive gold grains,
endoscopic radiation techniques, and photodynamic ther-
apy. However, this field ofinterventional bronchology is the
subject of further elaboration in another paper.
In conclusion, different locations of pulmonary
pathologies require a differenciated strategy of securing
sufficient material to make a definitive histopathological
diagnosis. Basedupon the advanced technique ofthe flex-
ible bronchoscope, well developed biopsy equipment,
easy availability and even the possibility to perform this
method on an outpatient basis, this investigation has be-
come the workhorse in establishing lung cancer.
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